|
|
|
|
|
|
|
06.05.26 - 00:06
|
Alcon Q1 Profit Falls (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Eye care products maker Alcon Inc. (ALC) on Tuesday reported first-quarter results, with profit declining from last year despite an increase in revenues. Net income for the ......
|
|
|
05.05.26 - 22:42
|
New Product Launches Drive Alcon′s First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds (Business Wire)
|
|
|
First-quarter 2026 sales of $2.7 billion, up 10% on a reported basis, or up 6% constant currency1 (cc), versus first-quarter 2025
First-quarter 2026 diluted EPS of $0.39; core diluted EPS2 of $0.85
Dividend of 0.28 CHF per share approved at AGM
Announced new $1.5 billion share repurchase authorization over 3 years
Ad Hoc Announcement Pursuant to Art. 53 LRGENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ending March 31, 2026. For the first quarter of 2026, sales were $2.7 billion, up 10% on a reported basis and up 6% on a constant currency basis1, as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.39 and core diluted earnings per share2 of $0.85 in the first quarter of 2026.
“2026 is off to a solid start, driven by strong performance from our new product launches, including Unity VCS and CS, PanOptix Pro, Tryptyr and Precision7. Combined with the resilience of our balanced ...
|
|
|
|
|
|
|
30.04.26 - 22:39
|
Alcon Announces Results of 2026 Annual General Meeting (Business Wire)
|
|
|
Shareholders approve all agenda items presented
R. Scott Herren elected as new independent member of the Board
2025 Compensation Report and Report on Non-Financial Matters approved in consultative votes
GENEVA--(BUSINESS WIRE)--Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2026 Annual General Meeting (“AGM”).
A total of 283,222,421 shares with a nominal value of CHF 0.04 each, representing an aggregate nominal value of CHF 11,328,896.84, were represented at today's AGM.
Shareholders re-elected F. Michael Ball as member and Chair of the Board of Directors, and the other members of the Board who stood for re-election, namely Lynn Bleil, Arthur Cummings, Deborah Di Sanzo, David Endicott, Thomas Glanzmann, D. Keith Grossman, Karen May, Ines Pöschel and Dieter Spälti, for a term of office of one year. Shareholders also elected R. Scott Herren to the Board.
In addition, shareholders re...
|
|
|
|
|
|
|
07.04.26 - 14:06
|
Tenpoint Therapeutics, Ltd. Appoints Stephen S. Lane, M.D., as Chief Medical Officer (Business Wire)
|
|
|
Ophthalmology Luminary and Former Alcon CMO Joins Tenpoint TherapeuticsLONDON & SEATTLE--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced the appointment of Stephen S. Lane, M.D., as Chief Medical Officer (CMO). In this role, Dr. Lane will join the executive team and oversee the Company's clinical development strategy, medical affairs and pharmacovigilance.
Dr. Lane brings significant ophthalmology leadership experience in clinical practice and the pharmaceutical industry, most recently serving as Chief Medical Officer and Head of Medical Safety at Alcon, Inc. He is recognized as a world-renowned ophthalmologist with more than 40 years of experience. Dr. Lane is the past President of the American Society of Cataract and Refractive Surgery (ASCRS), a former member of the Committee of Secretaries at the American Academy of Ophthalmology (AAO), a former Board...
|
|
|
|
|
|
|
02.04.26 - 22:39
|
Alcon Publishes Agenda for 2026 Annual General Meeting (Business Wire)
|
|
|
Alcon welcomes its shareholders to its fourth in-person AGM
Alcon Board of Directors proposes to elect R. Scott Herren as a new independent Board member
Proposed dividend of CHF 0.28 cash per share
GENEVA--(BUSINESS WIRE)--Regulatory News:
Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on April 30, 2026.
Alcon is pleased to welcome shareholders to its fourth in-person AGM since becoming an independent, standalone company. The company looks forward to hearing directly from its shareholders at this open format meeting.
Alcon's Board of Directors proposes to the AGM to elect R. Scott Herren as a new independent Board member. An accomplished financial executive with thirty-five years of experience, including most recently as the Chief Financial Officer of Cisco Systems, Inc., R. Scott Herren brings to the Board an extensive background in financial planning and strategy, corporate development, operations of global enterprises and internal controls over financi...
|
|
|
02.04.26 - 22:36
|
Alcon Publishes Agenda for 2026 Annual General Meeting (Business Wire)
|
|
|
Alcon welcomes its shareholders to its fourth in-person AGM
Alcon Board of Directors proposes to elect R. Scott Herren as a new independent Board member
Proposed dividend of CHF 0.28 cash per share
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on April 30, 2026.
Alcon is pleased to welcome shareholders to its fourth in-person AGM since becoming an independent, standalone company. The company looks forward to hearing directly from its shareholders at this open format meeting.
Alcon's Board of Directors proposes to the AGM to elect R. Scott Herren as a new independent Board member. An accomplished financial executive with thirty-five years of experience, including most recently as the Chief Financial Officer of Cisco Systems, Inc., R. Scott Herren brings to the Board an extensive background in financial planning and strategy, corporate development, operations of global enterprises and internal controls over financial reporting of p...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
